- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00713206
Prospective Study of NanoTite Implants Placed Into Fresh Sinus-Lift Augmentation Sites (VSSL)
A Prospective, Randomized-Controlled, Multicenter Study of NanoTite Implants Placed Into Fresh Sinus Lift Augmentation Sites
This prospective, randomized-controlled, clinical study evaluates the ability of the NanoTite implant system to achieve integration and provide long-term support of a prosthesis when placed immediately in fresh sinus augmentation material. Control cases will be those where the sinus augmentation material is allowed four months of healing prior to NanoTite implant placement. In addition to implant performance, radiographic evidence of crestal bone regressive modeling will be used to evaluate differences between test and control cases.
Study (null) hypothesis: The implants placed into sinus augmentation sites at the time of grafting will have the same integration success and maintenance of integration as for the implants placed after four months of graft healing.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This will be a prospective, randomized-controlled, longitudinal study in which qualified patients with partial edentulism and thin maxillary ridges will have as part of their treatment at least one sinus ridge augmentation procedure and have their edentulism restored with an implant-supported short-span or long-span fixed bridge. Each patient may have up to two cases included in the study should they need bilateral sinus augmentation using unilateral bridge restorations on either side.
Each patient (or side if a bilateral case) will be randomly assigned to one of two groups: Treatment Group 1 (test) cases will have implants placed into the sinus cavity during the graft augmentation procedure. Treatment Group 2 (control) will have a sinus lift augmentation and implant placement into this area will take place after four months of graft healing. For both groups the implants will be submerged and allowed four months of healing before second stage surgery.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Chieti, Italy
- Università "G. d' Annunzio" Chieti-Pescara
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients of either sex and any race greater than 18 years of age
- Patients for whom a decision has already been made to augment one or both maxillary sinuses for the purpose of placing dental implants in a maxillary ridge no less than 3 mm high and no greater than 5 mm in height
- Patients must be physically able to tolerate conventional surgical and restorative procedures.
- Patients must agree to be evaluated for each study visit, especially the yearly follow-up visit
Exclusion Criteria:
- Patients with active infection or severe inflammation in the areas intended for implant placement.
- Patients with a >10 cigarettes per day smoking habit.
- Patients with uncontrolled diabetes mellitus.
- Treatment with therapeutic radiation to the head within the past 12 months.
- Patients who are pregnant at the screening visit.
- Patients with evidence of severe para-functional habits such as bruxing or clenching.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Dental implant (Osseotite)
Dental implants placed simultaneously with graft augmentation material.
|
Root form titanium dental implant
Other Names:
|
No Intervention: Control group
Dental implants placed into graft augmentation material that has four months to heal.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Implants Not Mobile (Not Failing) at End of 3 Years
Time Frame: 3 years
|
All surviving implants at the end of study (3 years)
|
3 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Crestal Bone Loss (Measured Value of Bone Level Around the Dental Implant)
Time Frame: 3 year
|
Average measured bone loss (change from baseline) for each implant placed at 3 years final time frame
|
3 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Sergio Caputi, DDS, Director del Dipartimento di Scienze Odontostomatologiche
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2604
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Partial Edentulism
-
Nobel BiocareCompletedPartial Edentulism | Complete Edentulism
-
Nobel BiocareCompletedPartial Edentulism | Complete Edentulism
-
Semmelweis UniversityInstitut Straumann AG; Geistlich Pharma AG; Dicomlab Kft.Recruiting
-
Fundación Eduardo AnituaActive, not recruitingPartial-edentulismSpain
-
Fundación Eduardo AnituaActive, not recruitingPartial-edentulismSpain
-
University of Colorado, DenverCompletedPartial EdentulismUnited States
-
University of BaghdadUnknown
-
Navigate Surgical Technologies Inc.CompletedPartial EdentulismCanada
-
Institut Straumann AGCompletedPartial EdentulismUnited States, Austria, Germany, Ireland, Netherlands, Portugal, Spain, Sweden, Switzerland
-
Institut Straumann AGCompletedPartial Edentulism
Clinical Trials on Dental Implant (Osseotite)
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseUnited States
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseUnited States
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseChile
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseChile
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseColombia
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseChile
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseChile
-
Andres Duque DuqueZimmer BiometUnknownJaw, Edentulous, PartiallyColombia
-
ZimVieCompletedPartial Edentulism | Tooth DiseaseColombia
-
University of Alabama at BirminghamZimmer DentalCompleted